Journal article
Use of tetanus-diphtheria (Td) vaccine in children 4–7 years of age: World Health Organization consultation of experts
Td (reduced diphtheria toxoid, ≥2–5 IU) vaccines are currently licensed for ages 7 years and older, but use of Td vaccine for ages 4 years and older would have advantages for immunization programs in many low- and middle-income countries. For this reason, WHO convened an expert consultation to review the currently available evidence for the use of Td vaccine from 4 to 7 years of age.
Languages
- English
Publication year
2020
Journal
Vaccine
Volume
21
Type
Journal article
Categories
- Programme management
Diseases
- Tetanus
Organisations
- World Health Organisation (WHO)
Topic references
EPI-CORE-TETANUS
| Title | Author | Year | Type | Language |
|---|---|---|---|---|
| Protecting All Against Tetanus: Guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populations | World Health Organization (WHO) | 2019 | Guidance | French |
| Replacement of TT with Td vaccine – July 2018 | UNICEF, World Health Organization (WHO) | 2018 | Guidance | French |
| Tetanus serosurvey guidance | World Health Organization (WHO) | 2018 | Guidance | English |
| Use of tetanus-diphtheria (Td) vaccine in children 4–7 years of age: World Health Organization consultation of experts | Heather M. Scobie, S. Desai, Thomas Cherian, Tracey Goodman | 2020 | Journal article | English |
| Validation of Maternal and Neonatal Tetanus Elimination | World Health Organization (WHO) | 2014 | Guidance | English, French |
